Adagio Medical Holdings, INC. 8-K Filing
Ticker: ADGM · Form: 8-K · Filed: Dec 16, 2025 · CIK: 2006986
| Field | Detail |
|---|---|
| Company | Adagio Medical Holdings, INC. (ADGM) |
| Form Type | 8-K |
| Filed Date | Dec 16, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Adagio Medical Holdings, INC. (ticker: ADGM) to the SEC on Dec 16, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ch registered Common Stock, par value $0.0001 per share ADGM The Nasdaq Stock Marke).
How long is this filing?
Adagio Medical Holdings, INC.'s 8-K filing is 2 pages with approximately 550 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 550 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-12-16 16:15:32
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ADGM The Nasdaq Stock Marke
Filing Documents
- tm2533687d1_8k.htm (8-K) — 29KB
- 0001104659-25-121586.txt ( ) — 192KB
- adgm-20251215.xsd (EX-101.SCH) — 3KB
- adgm-20251215_lab.xml (EX-101.LAB) — 33KB
- adgm-20251215_pre.xml (EX-101.PRE) — 22KB
- tm2533687d1_8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On December 15, 2025, Adagio Medical Holdings, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). The stockholders considered two proposals, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on November 4, 2025 (the "Proxy Statement"). Of the 21,179,637 shares outstanding as of the record date, 13,862,436 shares, or 65.45%, were present or represented by proxy at the Annual Meeting. The final results for each of the matters submitted to the stockholders at the Annual Meeting are as follows: Proposal No 1 : Election of two nominees to serve as directors until the 2028 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: For Withheld Broker Non-Votes Todd Usen 12,915,589 19,972 926,875 James L. Cox, M.D. 11,610,366 1,325,195 926,875 Both nominees were elected. Proposal No 2 : Ratification of the appointment of WithumSmith+Brown, PC as independent registered public accounting firm for the fiscal year ending December 31, 2025. The votes were cast as follows: For Against Abstain Broker Non-Votes 13,407,336 352,547 102,553 — 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 16, 2025 Adagio Medical Holdings, Inc. By: /s/ Deborah Kaster Name: Deborah Kaster Title: Chief Financial Officer 3